{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=110248", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=110248", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=110248&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=110248&_page=0", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=110248", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=110248", "items" : [{"_about" : "http://data.parliament.uk/resources/1415967", "AnsweringBody" : [{"_value" : "Treasury"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1415967/answer", "answerText" : {"_value" : "<p>Recent estimates of the average length of time it takes for lorries to pass through customs at Dover have not been made. Short delays to freight movements have not been caused by new customs processes. The main causes were ship-fitting, which reduces capacity across the short straits, and higher than expected freight volumes. The Goods Vehicle Movement System and other customs systems are online and working as planned.<\/p><p> <\/p><p>The Borders are flowing, we are continuing to monitor the situation closely, and are engaging with industry groups and local stakeholders in Kent.<\/p><p> <\/p><p>We always act to preserve the flow, but we will not compromise on the security of the UK at the border. This includes fiscal security. HMRC continues to use a risk based, intelligence-led response to compliance issues working alongside Border Force.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4517", "label" : {"_value" : "Biography information for Lucy Frazer"}
        }
        , "answeringMemberConstituency" : {"_value" : "South East Cambridgeshire"}
        , "answeringMemberPrinted" : {"_value" : "Lucy Frazer"}
        , "dateOfAnswer" : {"_value" : "2022-01-27", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-01-27T17:57:09.037Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "14"}
      , "answeringDeptShortName" : {"_value" : "Treasury"}
      , "answeringDeptSortName" : {"_value" : "Treasury"}
      , "date" : {"_value" : "2022-01-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Customs: Port of Dover"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Chancellor of the Exchequer, what recent estimate he has made of the average length of time it takes for lorries to pass through customs at the Port of Dover.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/410", "label" : {"_value" : "Biography information for Jon Trickett"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hemsworth"}
      , "tablingMemberPrinted" : [{"_value" : "Jon Trickett"}
      ], "uin" : "110248"}
    , {"_about" : "http://data.parliament.uk/resources/1247737", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1247737/answer", "answerText" : {"_value" : "<p>The Foreign, Commonwealth and Development Office (FCDO) supports some of the poorest and most vulnerable people through social protection programmes in over 25 countries. We recognise their potential to deliver gender equality outcomes, including girls' education, and are working with governments and international partners to strengthen the gender responsiveness of social protection policies and programmes in developing countries. Our Gender-Responsive Social Protection and Better Assistance in Crises programmes are providing expert advice to FCDO country offices, governments and partner organisations on how to strengthen social protection measures in the COVID-19 response, including how to deliver more effectively for women and girls. We will continue to encourage a strong gender focus in social protection programmes and systems in the COVID-19 recovery.<\/p><p>The UK is committed to supporting children in developing countries to return to school when it is safe to do so, and recognises the important role social protection can play in safeguarding the wellbeing of individuals and their families during times of crisis, and in helping families to meet the direct and indirect costs of sending girls to schools. This is part of the FCDO's wider education programme response to COVID-19 which includes work with partner countries to ensure they have the knowledge and resources to facilitate a safe return.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
        }
        , "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
        , "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
        , "dateOfAnswer" : {"_value" : "2020-11-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2020-11-10T12:08:06.327Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "208"}
      , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
      , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
      , "date" : {"_value" : "2020-11-02", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Education: Children"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps the Government is taking to help ensure an expansion of gender-responsive social protection following the covid-19 pandemic to help keep children, particularly girls, in school.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4764", "label" : {"_value" : "Biography information for Bell Ribeiro-Addy"}
      }
      , "tablingMemberConstituency" : {"_value" : "Streatham"}
      , "tablingMemberPrinted" : [{"_value" : "Bell Ribeiro-Addy"}
      ], "uin" : "110248"}
    , {"_about" : "http://data.parliament.uk/resources/780496", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/780496/answer", "answerText" : {"_value" : "<p>The Medicines and Healthcare products Regulatory Agency (MHRA) encourages anyone to report a suspected adverse reaction (ADR) to a vaccine or medicine through the Yellow Card Scheme:<\/p><p> <\/p><p><a href=\"http://www.mhra.gov.uk/yellowcard\" target=\"_blank\">www.mhra.gov.uk/yellowcard<\/a><\/p><p>A Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine or medicine may have been the cause. Such reports are kept under continual review to identify potential new risks.<\/p><p> <\/p><p>Between 31 October 2014 \u2013 30 October 2017 a total of 649 serious suspected adverse reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card Scheme (data run date: 1 November 2017). In this three year period, at least 1 million doses of HPV vaccine were administered in the United Kingdom.<\/p><p> <\/p><p>A breakdown of UK serious suspected spontaneous ADR reports received via the Yellow Card Scheme beween 31 October 2014 \u2013 30 October 2016 by brand and year received is shown in the following table.<\/p><p> <\/p><table><tbody><tr><td><p>HPV Vaccine<\/p><\/td><td><p>Number of serious reports<\/p><\/td><\/tr><tr><td><p>HPV brand unspecified<\/p><\/td><td><p>181<\/p><\/td><\/tr><tr><td><p>Cervarix<\/p><\/td><td><p>64<\/p><\/td><\/tr><tr><td><p>Gardasil<\/p><\/td><td><p>390<\/p><\/td><\/tr><tr><td><p>Gardasil 9<\/p><\/td><td><p>18<\/p><\/td><\/tr><tr><td><p>Total<\/p><\/td><td><p>649<\/p><\/td><\/tr><\/tbody><\/table><p> <\/p><p>Source: MHRA sentinel database for adverse reactions<\/p><p> <\/p><p>Notes:<\/p><p> <\/p><p>The total number of reports received by vaccine brand is not equal to the totals in the table above as some reports included more than one HPV vaccine brand.<\/p><p> <\/p><p>The MHRA has received a total of 3,159 serious suspected adverse reaction reports associated with HPV vaccine (data run date 1 November 2017).<\/p><p> <\/p><p>All serious reports received via the Yellow Card Scheme are reviewed based on the details received from the reporter. Follow up letters may be sent for missing information such as vaccine brand name, batch number, medical history, results of investigations, diagnoses and details of outcome.<\/p><p> <\/p><p>The Commission on Human Medicines has thoroughly reviewed the safety of HPV vaccines and concluded that the evidence does not support a link between HPV vaccination and the development of chronic illnesses.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2017-11-07", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "110360"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-11-07T11:31:40.77Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2017-10-30", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, how many Yellow Cards submitted to the Medicines and Healthcare Products Regulatory Agency on the HPV vaccination have been classified as serious in the last three years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4663", "label" : {"_value" : "Biography information for Ben Bradley"}
      }
      , "tablingMemberConstituency" : {"_value" : "Mansfield"}
      , "tablingMemberPrinted" : [{"_value" : "Ben Bradley"}
      ], "uin" : "110248"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}